PIPRA AG

📍 Zurich, Switzerland🗓 Founded 2019👥 10 employees💰 Last funded Feb 2022
PIPRA has developed a cutting-edge AI-based pre-surgical tool to assess patients’ risk of suffering from POD or POCD. A reliable pre-surgical risk assessment is urgently needed to improve preventive measures, consequent surgical outcomes and thus patients’ quality of life. POCD & POD More than 25% of patients aged over 60 suffer from cognitive impairment due to surgical complications. Disorientation, memory loss, difficulty in speech, and behavioral changes are among the symptoms experienced by patients affected by Post-Operative Delirium (POD) and Post-Operative Cognitive Decline/Dysfunction (POCD). These cognitive disorders result in a longer post-surgical recovery time, with increased hospital stays and associated costs. In addition, the most severe forms of perioperative cognitive disorders can lead to the admission in nursing homes due to significant functional and cognitive decline. Today, there is no effective POD and POCD treatment currently available. It is therefore crucial to prevent the onset of these disorders.​
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in PIPRA AG?
PIPRA AG has 1 investors on record on gritt.io, 1 mid-stage.
When did PIPRA AG last raise funding?
The most recent investment in PIPRA AG recorded on gritt.io was in February 2022.
When was PIPRA AG founded?
PIPRA AG was founded in 2019.
What industry is PIPRA AG in?
PIPRA AG operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is PIPRA AG based?
PIPRA AG is headquartered in Zurich, Switzerland.